Therapy
Biotechnology
Health

Exelixis

6,166

$24.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.38 (+1.56%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Exelixis and other stocks, options, ETFs, and crypto commission-free!

About EXEL

Exelixis, Inc. Common Stock, also called Exelixis, is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. Read More It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA.

CEO
Michael M. Morrissey
Employees
617
Headquarters
Alameda, California
Founded
1994
Market Cap
7.58B
Price-Earnings Ratio
26.11
Dividend Yield
—
Average Volume
2.95M
High Today
$24.78
Low Today
$23.87
Open Price
$24.49
Volume
2.85M
52 Week High
$27.80
52 Week Low
$13.67

Collections

Therapy
Biotechnology
Health
Cancer Prevention
Pharmaceutical
Biopharmaceutical
Medical
Technology

EXEL News

ReutersMay 25

Edited Transcript of EXEL earnings conference call or presentation 5-May-20 9:00pm GMT

Q1 2020 Exelixis Inc Earnings Call SOUTH SAN FRANCISCO May 26, 2020 (Thomson StreetEvents) -- Edited Transcript of Exelixis Inc earnings conference call or pre
26

EXEL Earnings

$0.00
$0.14
$0.27
$0.41
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Jul 29, After Hours

You May Also Like

JPM-C
HCCHR
CSLT
FXH
ERF
ITVPY
MDT
CURE
JHSC
USCR
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy EXEL

Market Price$24.71
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Exelixis stock and options commission-free.
LearnBlogCareersHelpLog InSign Up